Fig. 2.

Lupeol in mono- and combination therapy reduced the migration of: A) MCF-7, B) MDA-MB-231 and C) HFF cells; Phase contrast images were taken immediately after scratch (0 h) and 24 h after treatment (24 h) and scratch distances were expressed as % of initial values (D, E and F). Asterisks are representing significant difference (p < 0.05) between the corresponding control and treated cells and # is indicating a significant difference between the cells that received the combination of LPL and DOX and/or each single compound. Scale bare represents 200 μm